>>> US Gapping up

Gapping up
In reaction to earnings/guidance
:

  • ACN +8.7%, APG +7.9% (raises FY21 revenue guidance), HEI +4.2%, JBL +3.4%, TCOM +3%, FLXS +1.6% (raises revenue guidance, but lowers margin guidance)

Other news:

  • CALT +36.7% (FDA approves TARPEYO)
  • FREY +14.5% (executed inaugural offtake agreement for at least 31 GWh of low-carbon battery cells with an undisclosed leading global publicly listed manufacturer)
  • VRCA +11.5% (FDA accepts NDA for VP-102 for molluscum contagiosum)
  • MESO +11.3% (FDA's OTAT in Agreement With 12-Month Reduction in Pain as Primary Endpoint for Chronic Low Back Pain Program)
  • GOEV +6.2% (to accelerate and shift production of EVs from Europe to US; increases production guidance and targets; also to explore partnership opportunities with VDL Groep)
  • PLUG +5.5% (Plug Power and Edison Motors sign agreement for mass-production of hydrogen-powered city buses)
  • MAXR +4.3% (reserves May 15 - Jun 13 window for WorldView Legion launch)
  • NVS +4.2% (initiates new $15 bln share buyback)
  • MTNB +4% (receives unanimous DSMB approval to progress into fourth and final cohort of patients in the EnACT Trial of MAT2203 )
  • STEM +3.8% (acquires Also Energy Holdings for $695 mln)
  • ZLAB +3.7% (receives approval for NUZYRA as a Category 1 Innovative Drug)
  • AFCG +2.8% (increases dividend)
  • HOFV +2.8% (closes on financing for Constellation Center for Excellence)
  • ATRS +2.8% (divests Otrexup)
  • SAND +2% (declares inaugural dividend of C$0.02/sh)
  • MARA +2% (Exec Chairman to retire)
  • DAL +2% (announces three-year financial targets and outlook details customer-centric approach at Capital Markets Day)
  • APRN +1.8% (plans for co-branded credit card with Aspiration)
  • RGLD +1.8% (provides details on fiscal year end change)
  • NVAX +1.4% (submits NDA for approval of COVID-19 vaccine in Japan)
  • AZO +1% (authorizes additional $1.5 bln in share repurchases)
  • V +0.9% (approves $12 bln share repurchase program)

Analyst comments:

  • BK +1.4% (upgraded to Overweight from Neutral at JP Morgan)
  • BKNG +1.4% (upgraded to Outperform from Sector Perform at RBC Capital Mkts)